PodcastDX

PodcastDX
PodcastDX

PodcastDX is an interview based weekly series. Guests share experience based medical insight for our global audience.  We have found that many people are looking for a platform, a way to share their voice and the story that their health journey has created. Each one is unique since even with the same diagnosis, symptoms and the way each person will react to a diagnosis, is different. Sharing what they have experienced and overcome is a powerful way our guests can teach others with similar ailments. Many of our guests are engaging in self-advocacy while navigating a health condition, many are complex and without a road-map to guide them along their journey they have developed their own. Sharing stories may help others avoid delays in diagnosis or treatment or just give hope to others that are listening. Sharing is empowering and has a healing quality of its own. Our podcast provides tips, hints, and support for common healthcare conditions. Our guests and our listeners are just like you- navigating the complex medical world. We hope to ease some tension we all face when confronted with a new diagnosis. We encourage anyone wanting to share their story with our listeners to email us at info@PodcastDX.com ​

  1. 2D AGO

    Hepatitis (Re-Run)

    Hepatitis means inflammation of the liver. The liver is a vital organ that processes nutrients, filters the blood, and fights infections. When the liver is inflamed or damaged, its function can be affected. Heavy alcohol use, toxins, some medications, and certain medical conditions can cause hepatitis. However, hepatitis is often caused by a virus. In the United States, the most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. ​Hepatitis D, also known as “delta hepatitis,” is a liver infection caused by the hepatitis D virus (HDV). Hepatitis D only occurs in people who are also infected with the hepatitis B virus. Hepatitis D is spread when blood or other body fluids from a person infected with the virus enters the body of someone who is not infected. Hepatitis D can be an acute, short-term infection or become a long-term, chronic infection. Hepatitis D can cause severe symptoms and serious illness that can lead to life-long liver damage and even death. People can become infected with both hepatitis B and hepatitis D viruses at the same time (known as “coinfection”) or get hepatitis D after first being infected with the hepatitis B virus (known as “superinfection”). There is no vaccine to prevent hepatitis D. However, prevention of hepatitis B with hepatitis B vaccine also protects against future hepatitis D infection. ​Hepatitis E is a liver infection caused by the hepatitis E virus (HEV). HEV is found in the stool of an infected person. It is spread when someone unknowingly ingests the virus – even in microscopic amounts. In developing countries, people most often get hepatitis E from drinking water contaminated by feces from people who are infected with the virus. In the United States and other developed countries where hepatitis E is not common, people have gotten sick with hepatitis E after eating raw or undercooked pork, venison, wild boar meat, or shellfish. In the past, most cases in developed countries involved people who have recently traveled to countries where hepatitis E is common. Symptoms of hepatitis E can include fatigue, poor appetite, stomach pain, nausea, and jaundice. However, many people with hepatitis E, especially young children, have no symptoms. Except for the rare occurrence of chronic hepatitis E in people with compromised immune systems, most people recover fully from the disease without any complications. No vaccine for hepatitis E is currently available in the United States. (credits CDC)

    11 min
  2. MAR 4

    Vectors in a Hotter World

    This week we discuss vectors in a hotter world.   Vector-borne diseases, which are transmitted by hematophagous arthropods such as mosquitoes, ticks, and sandflies, pose a significant burden on global public health. These diseases disproportionately affect populations in tropical and subtropical regions, where environmental conditions favor the survival and proliferation of vectors. Given that vectors are ectothermic organisms, their life cycles, reproduction, survival rates, and geographic distribution are heavily influenced by climate variables such as temperature, rainfall, and humidity. Consequently, changes in climate patterns can have profound effects on the transmission dynamics of vector-borne diseases, altering their geographic spread and intensity. Rising global temperatures have led to the expansion of vector habitats into previously unsuitable regions, including temperate zones. Warmer climates accelerate the development of many vectors and pathogens, reducing the extrinsic incubation period of viruses such as dengue, Zika, and chikungunya. Additionally, increased temperatures can extend the breeding season of mosquitoes like Aedes aegypti and Anopheles species, enhancing their capacity to transmit diseases such as malaria. Conversely, extreme heat events may reduce vector survival in some regions, leading to localized declines in transmission. ​Changes in precipitation patterns also play a crucial role in shaping vector distribution. Heavy rainfall events can create new breeding sites for mosquitoes by increasing the availability of stagnant water, while drought conditions may drive vectors closer to human settlements in search of water sources. In particular, shifts in rainfall patterns have been linked to outbreaks of malaria, dengue, and West Nile virus in various parts of the world. Increased humidity can further facilitate the survival of certain pathogens within vectors, enhancing their ability to transmit infections. Beyond climate variables, other anthropogenic factors contribute to the spread of vector-borne diseases. Land use changes, such as deforestation and urbanization, have disrupted natural ecosystems, bringing vectors and humans into closer contact. For example, deforestation in the Amazon has been associated with increased malaria transmission due to the creation of new breeding sites for Anopheles mosquitoes. Similarly, expanding urban populations with inadequate water management systems provide ideal conditions for the proliferation of Aedes mosquitoes, driving the rise in dengue and chikungunya cases. Globalization and human mobility further compound the issue by facilitating the movement of infected individuals and vectors across borders. Increased travel and trade have contributed to the introduction and establishment of vector-borne diseases in regions where they were previously rare. For instance, the spread of Aedes albopictus, a competent vector for dengue and chikungunya, has been linked to international trade in used tires and lucky bamboo plants, which serve as breeding grounds during transport. The multifaceted relationship between climate change and vector-borne diseases presents a challenge for public health interventions. While climate factors influence vector dynamics, their impact is often modulated by socio-economic conditions, infrastructure, and public health responses. To mitigate the growing threat of vector-borne diseases, an integrated approach is necessary—combining climate adaptation strategies, vector control measures, surveillance programs, and community engagement. Recent research underscores the importance of predictive modeling to anticipate outbreaks and inform public health policies. Advances in remote sensing, artificial intelligence, and climate modeling are enabling researchers to identify high-risk areas and implement targeted interventions. Strengthening early warning systems and investing in sustainable vector control strategies, such as genetically modified mosquitoes and Wolbachia-infected mosquito programs, offer promising avenues for reducing disease transmission. In conclusion, while climate change is reshaping the global landscape of vector-borne diseases, its effects are complex and intertwined with other environmental and societal factors. Understanding these dynamics is crucial for developing proactive strategies to mitigate the risks associated with the redistribution of vectors and the spread of diseases worldwide. By integrating climate science, epidemiology, and public health measures, we can better prepare for emerging threats and protect vulnerable populations from the growing impact of vector-borne diseases.

    14 min
  3. FEB 25

    Intro to Ehlers Danlos Syndrome

    This week we discuss the basics about a topic several of our guests have spoken about- Ehlers Danlos Syndrome or EDS.   ​Ehlers-Danlos syndrome is a group of inherited disorders that affect your connective tissues — primarily your skin, joints and blood vessel walls. Connective tissue is a complex mixture of proteins and other substances that provide strength and elasticity to the underlying structures in your body. ​The Ehlers-Danlos syndromes received a major overhaul in 2017 and this is what we now know: EDS are heritable connective tissue disorders affecting the quality of collagen in every part of the body. There are now 13 recognized subtypes of EDS, 12 of which are genuinely rare and have the aberrant gene identified. Hypermobile EDS (hEDS) and hypermobility spectrum disorder (HSD) is by far the most common type; these conditions are part of a spectrum and the distinction is hoped to be useful for research, but is otherwise academic. hEDS/HSD is a multi-system disorder which can have a marked impact on health and which may help us to explain apparently mysterious multiple symptoms. Don’t let the changing terminology confuse you. 3.4% of the population have generalized joint hypermobility and chronic widespread pain (a proxy for the now obsolete diagnosis of joint hypermobility syndrome (JHS). Patients who in the past received a diagnosis of JHS (or Benign JHS), EDS-Hypermobility Type or EDS Type III would now be categorized as having hEDS or HSD. “If you can’t connect the issues, think connective tissues” Non-specific and medically unexplained symptoms are usually real and should not be dismissed It can be easy to make a big difference to the quality of life of some of your most complex patients with a few simple and inexpensive measures, but the journey starts with recognition. The median time from symptom onset to seeking a GP opinion is 2 years and the median time to diagnosis 10 years. If we make an early diagnosis and manage the conditions appropriately, there may be potential to reduce long term disability which can occur from EDS. Enquire about family members; these are hereditary disorders of connective tissue so positive family histories are common. Although no gene has yet been identified, hEDS is primarily of autosomal dominant inheritance. Children can present with symptoms of hEDS/HSD, including abdominal symptoms or growing pains. They may also present with neurodevelopmental disorders such as hyperactivity, inattention, dyspraxia, autistic spectrum disorder, sleep, and food issues, emotional problems, hypersensitivity and anxiety. A low Beighton score does not exclude hEDS/HSD,. Patients stiffen with age so their Beighton score may decrease, although pain may worsen. The extent of multi-system symptoms is not related to the Beighton score. Consider co-existing conditions; In recent years, we have begun to understand more about associated or co-morbid conditions which are frequently found in people with hEDS, including autonomic dysfunction (postural tachycardia syndrome (PoTS) and symptomatic low blood pressure), mast cell activation syndrome (MCAS) and gastrointestinal dysfunction. (Credits: GPTOOLKIT)

    11 min
    4.9
    out of 5
    28 Ratings

    About

    PodcastDX is an interview based weekly series. Guests share experience based medical insight for our global audience.  We have found that many people are looking for a platform, a way to share their voice and the story that their health journey has created. Each one is unique since even with the same diagnosis, symptoms and the way each person will react to a diagnosis, is different. Sharing what they have experienced and overcome is a powerful way our guests can teach others with similar ailments. Many of our guests are engaging in self-advocacy while navigating a health condition, many are complex and without a road-map to guide them along their journey they have developed their own. Sharing stories may help others avoid delays in diagnosis or treatment or just give hope to others that are listening. Sharing is empowering and has a healing quality of its own. Our podcast provides tips, hints, and support for common healthcare conditions. Our guests and our listeners are just like you- navigating the complex medical world. We hope to ease some tension we all face when confronted with a new diagnosis. We encourage anyone wanting to share their story with our listeners to email us at info@PodcastDX.com ​

    You Might Also Like

    Content Restricted

    This episode can’t be played on the web in your country or region.

    To listen to explicit episodes, sign in.

    Stay up to date with this show

    Sign in or sign up to follow shows, save episodes, and get the latest updates.

    Select a country or region

    Africa, Middle East, and India

    Asia Pacific

    Europe

    Latin America and the Caribbean

    The United States and Canada